BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18337154)

  • 1. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
    Diebold I; Djordjevic T; Hess J; Görlach A
    Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
    Hecker M; Zaslona Z; Kwapiszewska G; Niess G; Zakrzewicz A; Hergenreider E; Wilhelm J; Marsh LM; Sedding D; Klepetko W; Lohmeyer J; Dimmeler S; Seeger W; Weissmann N; Schermuly RT; Kneidinger N; Eickelberg O; Morty RE
    Am J Respir Crit Care Med; 2010 Sep; 182(6):805-18. PubMed ID: 20522789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension.
    Papakonstantinou E; Kouri FM; Karakiulakis G; Klagas I; Eickelberg O
    Eur Respir J; 2008 Dec; 32(6):1504-12. PubMed ID: 18768572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Ikeda T; Nakamura K; Akagi S; Kusano KF; Matsubara H; Fujio H; Ogawa A; Miura A; Miura D; Oto T; Yamanaka R; Otsuka F; Date H; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):39-48. PubMed ID: 19786891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered nano/micro-order elasticity of pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Nakamura K; Shimizu J; Kataoka N; Hashimoto K; Ikeda T; Fujio H; Ohta-Ogo K; Ogawa A; Miura A; Mohri S; Nagase S; Morita H; Kusano KF; Date H; Matsubara H; Mochizuki S; Hashimoto K; Kajiya F; Ohe T
    Int J Cardiol; 2010 Apr; 140(1):102-7. PubMed ID: 19073348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sGC activator inhibits the proliferation and migration, promotes the apoptosis of human pulmonary arterial smooth muscle cells via the up regulation of plasminogen activator inhibitor-2.
    Zhang S; Zou L; Yang T; Yang Y; Zhai Z; Xiao F; Wang C
    Exp Cell Res; 2015 Mar; 332(2):278-87. PubMed ID: 25704756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
    Chen Y; Budd RC; Kelm RJ; Sobel BE; Schneider DJ
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells.
    Atsuta H; Uchiyama T; Kanai H; Iso T; Tanaka T; Suga T; Maeno T; Arai M; Nagai R; Kurabayashi M
    Int J Cardiol; 2009 Mar; 132(3):411-8. PubMed ID: 18471910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
    Pei L; Shan SM; Sun XY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):40-5. PubMed ID: 18346379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 is a novel component of the miR-17~92 signaling that regulates pulmonary artery smooth muscle cell phenotypes.
    Chen T; Huang JB; Dai J; Zhou Q; Raj JU; Zhou G
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L149-L161. PubMed ID: 29644896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
    Nordt TK; Lutzi S; Ruef J; Peter K; Klar E; Kübler W; Sobel BE; Bode C
    Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
    Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
    Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
    Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
    J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
    Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'PAI-1 paradox' in vascular remodeling.
    Diebold I; Kraicun D; Bonello S; Görlach A
    Thromb Haemost; 2008 Dec; 100(6):984-91. PubMed ID: 19132221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apoptosis versus proliferation activities of pulmonary artery smooth muscle cells in pulmonary arterial hypertension associated with chronic obstructive pulmonary disease].
    Yu WC; Guo CH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):657-61. PubMed ID: 18070547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.